We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$75.5B
AUM Growth
+$6.03B
(+8.7%)
Cap. Flow
+$664M
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
13.76%
Holding
1,022
New
110
Increased
407
Reduced
342
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Televisa
TV
|
+$308M |
| 2 |
AGN
Allergan Inc
AGN
|
+$239M |
| 3 |
Western Digital
WDC
|
+$185M |
| 4 |
Zoetis
ZTS
|
+$167M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$440M |
| 2 |
Qualcomm
QCOM
|
+$412M |
| 3 |
Baidu
BIDU
|
+$207M |
| 4 |
United Parcel Service
UPS
|
+$185M |
| 5 |
Coca-Cola
KO
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 16.71% |
| 2 | Financials | 13.65% |
| 3 | Communication Services | 11.71% |
| 4 | Technology | 11.31% |
| 5 | Healthcare | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Brown-Forman Class B
BF.B
$12B
| $131M | 0.17% |
5,992,947
+233,469
| +4% | +$5.26M |
|
152
Martin Midstream Partners
MMLP
$95.9M
| $130M | 0.17% |
2,778,134
+362,000
| +15% | +$16.4M |
|
153
Merck
MRK
$324B
| $129M | 0.17% |
2,836,402
-203,699
| -7% | -$9.3M |
|
154
Cardinal Health
CAH
$53.4B
| $129M | 0.17% |
2,468,513
+294,602
| +14% | +$15M |
|
|
TFCFA
155
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $128M | 0.17% |
+3,832,650
| New | +$121M |
|
156
Salesforce
CRM
$134B
| $128M | 0.17% |
2,463,880
-578,490
| -19% | -$26.3M |
|
157
IMAX
IMAX
$2.38B
| $127M | 0.17% |
4,194,815
-1,108
| -0% | -$29.8K |
|
158
CME Group
CME
$92.2B
| $127M | 0.17% |
1,715,918
-483,430
| -22% | -$35.6M |
|
159
NetEase
NTES
$76.5B
| $126M | 0.17% |
8,704,050
-11,298,745
| -56% | -$154M |
|
160
Johnson & Johnson
JNJ
$635B
| $126M | 0.17% |
1,456,967
+172,230
| +13% | +$15.5M |
|
|
CERN
161
DELISTED
Cerner Corp
CERN
| $126M | 0.17% |
2,391,230
-8,790
| -0.4% | -$428K |
|
162
Flowers Foods
FLO
$1.64B
| $125M | 0.17% |
5,830,866
+1,430,573
| +33% | +$32M |
|
|
PVR
163
DELISTED
PVR PARTNERS L P COM UNIT REPTG LTD PARTNERSHIP INT
PVR
| $124M | 0.16% |
5,349,611
+2,260,108
| +73% | +$56.4M |
|
164
Fortune Brands Innovations
FBIN
$6.12B
| $122M | 0.16% |
3,437,870
+561,015
| +20% | +$19.1M |
|
165
LyondellBasell Industries
LYB
$19.5B
| $122M | 0.16% |
1,668,001
+326,699
| +24% | +$22.7M |
|
166
Amdocs
DOX
$5.53B
| $122M | 0.16% |
3,326,707
+277,456
| +9% | +$10.5M |
|
167
Union Pacific
UNP
$183B
| $121M | 0.16% |
1,554,858
-354,020
| -19% | -$28M |
|
|
TLP
168
DELISTED
Transmontaigne
TLP
| $121M | 0.16% |
2,958,781
+1,507,618
| +104% | +$63.2M |
|
169
Morgan Stanley
MS
$337B
| $120M | 0.16% |
4,448,902
+81,454
| +2% | +$2.19M |
|
170
EOG Resources
EOG
$78B
| $120M | 0.16% |
1,413,960
+233,860
| +20% | +$18.1M |
|
171
Wabtec
WAB
$51.1B
| $119M | 0.16% |
1,896,696
+38,508
| +2% | +$2.26M |
|
|
LLL
172
DELISTED
L3 Technologies, Inc.
LLL
| $119M | 0.16% |
1,258,216
-843,362
| -40% | -$77.7M |
|
173
Universal Health Services
UHS
$9.43B
| $116M | 0.15% |
1,546,931
+718,770
| +87% | +$50.1M |
|
174
International Paper
IP
$22.3B
| $115M | 0.15% |
2,738,348
+1,244,358
| +83% | +$55.4M |
|
175
Freeport-McMoran
FCX
$90B
| $113M | 0.15% |
3,402,000
-434,250
| -11% | -$13.3M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2013 Portfolio in Review
As of Q3 2013, OppenheimerFunds held 1,022 positions worth $75.5B, up 8.7% from $69.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2013 filing shows 110 new, 407 increased, 342 reduced and 107 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M. The largest sale was Allergan plc, an estimated $440M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Financials and Communication Services.
- OppenheimerFunds's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M.
- OppenheimerFunds added most to Televisa in Q3 2013, an estimated $308M increase.
- OppenheimerFunds's biggest Q3 2013 reduction was Allergan plc, cutting an estimated $440M.
- OppenheimerFunds fully exited BROADCOM CORP CL-A in Q3 2013, selling an estimated $164M.
- OppenheimerFunds's ten largest holdings make up 14% of its $75.5B portfolio in Q3 2013.
- OppenheimerFunds opened 110 new positions and closed 107 in Q3 2013.
- OppenheimerFunds's portfolio value rose 8.7% quarter-over-quarter to $75.5B.
Based on OppenheimerFunds's 13F filing for Q3 2013, filed 14 Nov 2013.